Target intelligence / Profile preview

STIM2 antisense RNA 1 (STIM2-AS1)

Target
STIM2-AS1
Molecular classification
Long non-coding RNA, Antisense RNA
01

Overview

STIM2 antisense RNA 1 (STIM2-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense direction relative to the STIM2 gene. It is not a protein, enzyme, receptor, ion channel, or other canonical drug target, but instead belongs to the class of non-coding RNAs which may have regulatory functions at the transcriptional or post-transcriptional level. Currently, there are no definitive published data describing its specific molecular function, interacting proteins, involvement in disease, or potential as a therapeutic target. It is important to note that many references to "STIM2" in the literature refer specifically to the stromal interaction molecule 2 protein, not to the STIM2-AS1 lncRNA. If you are seeking information on a drug target, note that STIM2-AS1 is not a recognized therapeutic target. The canonical drug target is stromal interaction molecule 2 (STIM2), a calcium sensor and protein, not STIM2-AS1. Most published functional and disease data relate to the protein and not to the antisense RNA. Notes: - The search results provided do not reference STIM2-AS1, and all detailed published findings discuss "STIM2" as a protein involved in calcium signaling (a known drug target), not the antisense RNA[1][2][3][4][5]. - If you meant "STIM2" (stromal interaction molecule 2), please clarify; otherwise, STIM2-AS1, as an lncRNA, should not be classified as a canonical drug target. Summary: STIM2 antisense RNA 1 (STIM2-AS1) is a non-coding transcript with unclear biological functions and no established role as a therapeutic target. Most literature refers to the protein STIM2, not to the antisense RNA. If information on a drug target is required, review "STIM2" (stromal interaction molecule 2) rather than STIM2-AS1.

Other names
STIM2-AS1STIM2 antisense RNA 1
02

Biological functions

likely involved in gene expression regulation; specific functions not clearly reported

Beyond the preview

Go deeper on STIM2 antisense RNA 1 (STIM2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STIM2 antisense RNA 1 (STIM2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call